172 related articles for article (PubMed ID: 32277008)
1. Effects of Weight Loss and Weight Regain on Circulating Biomarkers in Overweight/Obese Breast Cancer Survivors Enrolled in a Weight Loss Trial in the Rural Midwest.
Befort CA; Kimler BF; Bantis LE; Phillips TA; Fabian CJ
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1321-1328. PubMed ID: 32277008
[TBL] [Abstract][Full Text] [Related]
2. WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Adiponectin and Leptin Levels in Breast Cancer Survivors with Overweight or Obesity.
Lin D; Sturgeon KM; Gordon BR; Brown JC; Sears DD; Sarwer DB; Schmitz KH
Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571390
[TBL] [Abstract][Full Text] [Related]
3. Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors.
Thompson HJ; Sedlacek SM; Wolfe P; Paul D; Lakoski SG; Playdon MC; McGinley JN; Matthews SB
Nutrients; 2015 Jun; 7(7):5156-76. PubMed ID: 26132992
[TBL] [Abstract][Full Text] [Related]
4. Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese.
Rock CL; Pande C; Flatt SW; Ying C; Pakiz B; Parker BA; Williams K; Bardwell WA; Heath DD; Nichols JF
Clin Breast Cancer; 2013 Jun; 13(3):188-95. PubMed ID: 23375717
[TBL] [Abstract][Full Text] [Related]
5. Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women.
Fabian CJ; Kimler BF; Donnelly JE; Sullivan DK; Klemp JR; Petroff BK; Phillips TA; Metheny T; Aversman S; Yeh HW; Zalles CM; Mills GB; Hursting SD
Breast Cancer Res Treat; 2013 Nov; 142(1):119-32. PubMed ID: 24141897
[TBL] [Abstract][Full Text] [Related]
6. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors.
Toriola AT; Liu J; Ganz PA; Colditz GA; Yang L; Izadi S; Naughton MJ; Schwartz AL; Wolin KY
Breast Cancer Res Treat; 2015 Aug; 152(3):637-43. PubMed ID: 26175059
[TBL] [Abstract][Full Text] [Related]
7. Body weight management in overweight and obese breast cancer survivors.
Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
[TBL] [Abstract][Full Text] [Related]
8. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.
Rock CL; Flatt SW; Byers TE; Colditz GA; Demark-Wahnefried W; Ganz PA; Wolin KY; Elias A; Krontiras H; Liu J; Naughton M; Pakiz B; Parker BA; Sedjo RL; Wyatt H
J Clin Oncol; 2015 Oct; 33(28):3169-76. PubMed ID: 26282657
[TBL] [Abstract][Full Text] [Related]
9. Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Travier N; Buckland G; Vendrell JJ; Fernandez-Veledo S; Peiró I; Del Barco S; Pernas S; Zamora E; Bellet M; Margeli M; Cirauqui B; Muñoz M; Tusquets I; Arcusa A; Javierre C; Moreno F; Rodriguez A; Agudo A
Eur J Cancer Care (Engl); 2018 Jul; 27(4):e12861. PubMed ID: 29869823
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin, leptin, adiponectin, and insulin levels and concurrent and future weight change in overweight, postmenopausal women.
Soni AC; Conroy MB; Mackey RH; Kuller LH
Menopause; 2011 Mar; 18(3):296-301. PubMed ID: 21449093
[TBL] [Abstract][Full Text] [Related]
11. The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.
Santa-Maria CA; Coughlin JW; Sharma D; Armanios M; Blackford AL; Schreyer C; Dalcin A; Carpenter A; Jerome GJ; Armstrong DK; Chaudhry M; Cohen GI; Connolly RM; Fetting J; Miller RS; Smith KL; Snyder C; Wolfe A; Wolff AC; Huang CY; Appel LJ; Stearns V
Clin Cancer Res; 2020 Jun; 26(12):3024-3034. PubMed ID: 32071117
[TBL] [Abstract][Full Text] [Related]
12. Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.
Sedjo RL; Flatt SW; Byers T; Colditz GA; Demark-Wahnefried W; Ganz PA; Wolin KY; Elias A; Krontiras H; Liu J; Naughton M; Pakiz B; Parker BA; Wyatt H; Rock CL
Support Care Cancer; 2016 Aug; 24(8):3285-93. PubMed ID: 26945570
[TBL] [Abstract][Full Text] [Related]
13. The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain.
Lien LF; Haqq AM; Arlotto M; Slentz CA; Muehlbauer MJ; McMahon RL; Rochon J; Gallup D; Bain JR; Ilkayeva O; Wenner BR; Stevens RD; Millington DS; Muoio DM; Butler MD; Newgard CB; Svetkey LP
OMICS; 2009 Feb; 13(1):21-35. PubMed ID: 19290809
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genetic variation in leptin as determinants of weight regain.
Erez G; Tirosh A; Rudich A; Meiner V; Schwarzfuchs D; Sharon N; Shpitzen S; Blüher M; Stumvoll M; Thiery J; Fiedler GM; Friedlander Y; Leiterstdorf E; Shai I
Int J Obes (Lond); 2011 Jun; 35(6):785-792. PubMed ID: 21042325
[TBL] [Abstract][Full Text] [Related]
15. The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: a randomized controlled trial.
Mason C; Xiao L; Imayama I; Duggan CR; Campbell KL; Kong A; Wang CY; Alfano CM; Blackburn GL; Foster-Schubert KE; McTiernan A
Clin Endocrinol (Oxf); 2015 Mar; 82(3):369-76. PubMed ID: 24796864
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment circulating leptin/ghrelin ratio as a non-invasive marker to identify patients likely to regain the lost weight after an energy restriction treatment.
Crujeiras AB; Díaz-Lagares A; Abete I; Goyenechea E; Amil M; Martínez JA; Casanueva FF
J Endocrinol Invest; 2014 Feb; 37(2):119-26. PubMed ID: 24497210
[TBL] [Abstract][Full Text] [Related]
17. Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels.
Crujeiras AB; Goyenechea E; Abete I; Lage M; Carreira MC; Martínez JA; Casanueva FF
J Clin Endocrinol Metab; 2010 Nov; 95(11):5037-44. PubMed ID: 20719836
[TBL] [Abstract][Full Text] [Related]
18. Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol.
Sedlacek SM; Playdon MC; Wolfe P; McGinley JN; Wisthoff MR; Daeninck EA; Jiang W; Zhu Z; Thompson HJ
BMC Cancer; 2011 Jul; 11():287. PubMed ID: 21733177
[TBL] [Abstract][Full Text] [Related]
19. Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors.
Pakiz B; Flatt SW; Bardwell WA; Rock CL; Mills PJ
Int J Behav Med; 2011 Dec; 18(4):333-41. PubMed ID: 21336679
[TBL] [Abstract][Full Text] [Related]
20. The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote.
Sheng JY; Santa-Maria CA; Blackford AL; Lim D; Carpenter A; Smith KL; Cohen GI; Coughlin J; Appel LJ; Stearns V; Snyder C
J Cancer Surviv; 2022 Jun; 16(3):542-551. PubMed ID: 34018096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
